$2.47 Billion is the total value of Nantahala Capital Management's 102 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 21.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $327,540,000 | -19.2% | 2,000,000 | -25.1% | 13.26% | -27.4% |
| FCAU | Buy | FIAT CHRYSLER AUTOMOBILES Ncall | $136,008,000 | +107.1% | 7,200,000 | +125.0% | 5.51% | +86.1% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcall | $111,890,000 | -28.2% | 2,276,500 | -39.2% | 4.53% | -35.5% |
| EXAS | Sell | EXACT SCIENCES CORPput | $111,736,000 | +45.8% | 1,868,800 | -1.6% | 4.52% | +31.0% |
| CDXS | CODEXIS INC | $96,191,000 | +30.9% | 6,679,954 | 0.0% | 3.89% | +17.6% | |
| SPY | SPDR S&P 500 ETF TRput | $94,948,000 | +3.1% | 350,000 | 0.0% | 3.84% | -7.4% | |
| AABA | ALTABA INC | $85,779,000 | -1.1% | 1,171,691 | 0.0% | 3.47% | -11.2% | |
| WRLD | Buy | WORLD ACCEP CORP DEL | $68,460,000 | +34.1% | 616,705 | +27.2% | 2.77% | +20.4% |
| QURE | Buy | UNIQURE NVcall | $68,040,000 | +479.1% | 1,800,000 | +260.0% | 2.76% | +419.8% |
| ARQL | ARQULE INC | $67,588,000 | +92.0% | 12,222,130 | 0.0% | 2.74% | +72.5% | |
| QURE | Sell | UNIQURE NV | $66,393,000 | +53.6% | 1,756,439 | -4.5% | 2.69% | +37.9% |
| THC | Sell | TENET HEALTHCARE CORP | $53,857,000 | +33.9% | 1,604,325 | -3.3% | 2.18% | +20.2% |
| GDEN | Buy | GOLDEN ENTMT INC | $52,833,000 | +23.3% | 1,957,510 | +6.1% | 2.14% | +10.8% |
| XBI | Buy | SPDR SERIES TRUSTput | $52,355,000 | +198.4% | 550,000 | +175.0% | 2.12% | +168.0% |
| RH | Sell | RHcall | $48,350,000 | -7.1% | 346,100 | -36.6% | 1.96% | -16.5% |
| CASH | Sell | META FINL GROUP INC | $46,734,000 | -11.2% | 479,814 | -0.4% | 1.89% | -20.2% |
| LXFR | LUXFER HOLDINGS PLC | $46,248,000 | +36.6% | 2,645,749 | 0.0% | 1.87% | +22.7% | |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $45,141,000 | +39.9% | 4,523,111 | +33.6% | 1.83% | +25.7% |
| DLB | Buy | DOLBY LABORATORIES INC | $38,573,000 | +23.3% | 625,270 | +27.0% | 1.56% | +10.8% |
| SODA | SODASTREAM INTERNATIONAL LTDcall | $38,385,000 | -7.1% | 450,000 | 0.0% | 1.55% | -16.5% | |
| QADA | QAD INCcl a | $34,444,000 | +20.4% | 686,814 | 0.0% | 1.39% | +8.1% | |
| PRTY | Buy | PARTY CITY HOLDCO INC | $32,595,000 | +16.2% | 2,137,401 | +18.9% | 1.32% | +4.4% |
| XELA | Buy | EXELA TECHNOLOGIES INC | $31,647,000 | +25.7% | 6,662,582 | +46.3% | 1.28% | +12.9% |
| NTRI | New | NUTRI SYS INC NEWput | $30,800,000 | – | 800,000 | +100.0% | 1.25% | – |
| CURO | Buy | CURO GROUP HLDGS CORP | $30,688,000 | +79.2% | 1,229,999 | +23.5% | 1.24% | +60.9% |
| DXPE | Buy | DXP ENTERPRISES INC NEW | $29,563,000 | +19.0% | 773,900 | +21.3% | 1.20% | +6.9% |
| SPY | Sell | SPDR S&P 500 ETF TRcall | $27,128,000 | -74.2% | 100,000 | -75.0% | 1.10% | -76.9% |
| ONDK | ON DECK CAP INC | $26,252,000 | +25.2% | 3,750,270 | 0.0% | 1.06% | +12.5% | |
| SGMS | Sell | SCIENTIFIC GAMES CORP | $25,809,000 | +12.8% | 525,100 | -4.5% | 1.04% | +1.4% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $23,414,000 | +28.0% | 2,213,052 | +20.0% | 0.95% | +14.9% |
| AFI | Buy | ARMSTRONG FLOORING INC | $23,208,000 | +19.7% | 1,653,016 | +15.7% | 0.94% | +7.6% |
| ENT | GLOBAL EAGLE ENTMT INC | $22,687,000 | +71.4% | 9,002,629 | 0.0% | 0.92% | +54.0% | |
| SODA | Buy | SODASTREAM INTERNATIONAL LTD | $20,882,000 | +19.7% | 244,810 | +28.9% | 0.84% | +7.5% |
| HCA | HCA HEALTHCARE INCput | $20,520,000 | +5.8% | 200,000 | 0.0% | 0.83% | -4.9% | |
| SGYPQ | SYNERGY PHARMACEUTICALS DEL | $20,147,000 | -4.9% | 11,578,568 | 0.0% | 0.82% | -14.6% | |
| JMBA | JAMBA INC | $19,541,000 | +24.1% | 1,834,835 | 0.0% | 0.79% | +11.4% | |
| THC | Sell | TENET HEALTHCARE CORPcall | $18,464,000 | -61.9% | 550,000 | -72.5% | 0.75% | -65.8% |
| HRB | BLOCK H & R INCput | $18,224,000 | -10.4% | 800,000 | 0.0% | 0.74% | -19.4% | |
| TBBK | Buy | BANCORP INC DEL | $17,901,000 | +1.2% | 1,711,379 | +4.4% | 0.72% | -9.1% |
| ADT | New | ADT INCcall | $17,300,000 | – | 2,000,000 | +100.0% | 0.70% | – |
| WRLD | Sell | WORLD ACCEP CORP DELcall | $17,218,000 | -43.5% | 155,100 | -46.4% | 0.70% | -49.2% |
| CRHM | Buy | CRH MEDICAL CORP | $15,396,000 | +55.4% | 4,919,614 | +25.5% | 0.62% | +39.4% |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $14,653,000 | -60.2% | 2,466,840 | -59.0% | 0.59% | -64.3% |
| BPI | Buy | BRIDGEPOINT ED INC | $13,885,000 | +191.2% | 2,126,338 | +200.5% | 0.56% | +161.4% |
| HTZGQ | HERTZ GLOBAL HLDGS INCcall | $12,272,000 | -22.7% | 800,000 | 0.0% | 0.50% | -30.6% | |
| FNTE | Buy | FINTECH ACQUISITION CORP II | $12,045,000 | +100.4% | 1,204,498 | +99.3% | 0.49% | +80.1% |
| GM | New | GENERAL MTRS COput | $11,820,000 | – | 300,000 | +100.0% | 0.48% | – |
| ORM | OWENS RLTY MTG INC | $11,119,000 | +14.4% | 666,630 | 0.0% | 0.45% | +2.7% | |
| OSPRU | OSPREY ENERGY ACQUISITION COunit 07/21/2022 | $10,925,000 | +8.2% | 1,000,000 | 0.0% | 0.44% | -2.9% | |
| VIVE | Buy | VIVEVE MED INC | $10,739,000 | +3.1% | 3,948,132 | +38.7% | 0.44% | -7.4% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $10,560,000 | – | 825,000 | +100.0% | 0.43% | – |
| FTDCQ | Buy | FTD COS INC | $10,202,000 | +30.2% | 2,198,663 | +2.2% | 0.41% | +17.0% |
| DHX | Buy | DHI GROUP INC | $9,685,000 | +137.8% | 4,121,092 | +69.5% | 0.39% | +113.0% |
| ELVT | ELEVATE CREDIT INC | $9,630,000 | +19.5% | 1,138,326 | 0.0% | 0.39% | +7.4% | |
| GLMD | Buy | GALMED PHARMACEUTICALS LTD | $8,819,000 | +413.0% | 741,108 | +140.1% | 0.36% | +363.6% |
| AKBA | Buy | AKEBIA THERAPEUTICS INCcall | $8,493,000 | +197.1% | 851,000 | +183.7% | 0.34% | +166.7% |
| CCXI | Buy | CHEMOCENTRYX INC | $8,102,000 | -0.8% | 615,173 | +2.4% | 0.33% | -10.9% |
| F | New | FORD MTR CO DELput | $7,749,000 | – | 700,000 | +100.0% | 0.31% | – |
| TLYS | TILLYS INCcl a | $7,758,000 | +34.1% | 512,103 | 0.0% | 0.31% | +20.3% | |
| GAIA | Sell | GAIA INC NEWcl a | $7,047,000 | +13.4% | 347,996 | -13.2% | 0.28% | +1.8% |
| RRR | Sell | RED ROCK RESORTS INCput | $6,700,000 | -29.6% | 200,000 | -38.5% | 0.27% | -36.8% |
| TAXA | Buy | LIBERTY TAX INCcl a | $6,527,000 | -4.8% | 808,239 | +19.0% | 0.26% | -14.6% |
| EMMS | EMMIS COMMUNICATIONS CORP | $5,782,000 | +14.7% | 1,092,951 | 0.0% | 0.23% | +3.1% | |
| ACER | ACER THERAPEUTICS INC | $5,405,000 | +12.1% | 250,252 | 0.0% | 0.22% | +0.9% | |
| NATR | NATURES SUNSHINE PRODUCTS IN | $5,391,000 | -15.0% | 576,602 | 0.0% | 0.22% | -23.8% | |
| RRTS | New | ROADRUNNER TRNSN SVCS HLDG I | $5,331,000 | – | 2,550,500 | +100.0% | 0.22% | – |
| CUE | New | CUE BIOPHARMA INC | $5,024,000 | – | 423,580 | +100.0% | 0.20% | – |
| ASCMA | Buy | ASCENT CAP GROUP INC | $4,620,000 | +9.9% | 1,644,260 | +44.0% | 0.19% | -1.1% |
| SHOS | SEARS HOMETOWN & OUTLET STOR | $4,570,000 | -30.0% | 2,176,251 | 0.0% | 0.18% | -37.1% | |
| APEN | New | APOLLO ENDOSURGERY INC | $4,537,000 | – | 649,941 | +100.0% | 0.18% | – |
| JYNT | New | JOINT CORP | $4,375,000 | – | 534,822 | +100.0% | 0.18% | – |
| SSKN | New | STRATA SKIN SCIENCES INC | $4,261,000 | – | 2,078,582 | +100.0% | 0.17% | – |
| RFL | New | RAFAEL HLDGS INC | $4,054,000 | – | 441,092 | +100.0% | 0.16% | – |
| MFCB | Buy | MFC BANCORP LTD | $3,993,000 | +21.3% | 674,555 | +27.3% | 0.16% | +9.5% |
| DVD | DOVER MOTORSPORTS INC | $3,883,000 | +7.1% | 1,725,789 | 0.0% | 0.16% | -3.7% | |
| LINC | LINCOLN EDL SVCS CORP | $3,758,000 | -12.6% | 2,159,705 | 0.0% | 0.15% | -21.6% | |
| KIRK | New | KIRKLANDS INCput | $3,492,000 | – | 300,000 | +100.0% | 0.14% | – |
| DDE | DOVER DOWNS GAMING & ENTMT I | $3,358,000 | +33.8% | 1,886,458 | 0.0% | 0.14% | +20.4% | |
| TA | Buy | TRAVELCENTERS AMER LLC | $2,658,000 | +9.2% | 759,401 | +12.3% | 0.11% | -1.8% |
| STRM | STREAMLINE HEALTH SOLUTIONS | $2,570,000 | -20.7% | 1,760,297 | 0.0% | 0.10% | -28.8% | |
| SHLDQ | SEARS HLDGS CORP | $2,494,000 | -11.2% | 1,052,490 | 0.0% | 0.10% | -20.5% | |
| SHLDQ | SEARS HLDGS CORPcall | $2,370,000 | -11.2% | 1,000,000 | 0.0% | 0.10% | -20.0% | |
| SHLDQ | SEARS HLDGS CORPput | $2,370,000 | -11.2% | 1,000,000 | 0.0% | 0.10% | -20.0% | |
| RLGT | RADIANT LOGISTICS INC | $2,054,000 | +1.0% | 525,300 | 0.0% | 0.08% | -9.8% | |
| TISI | New | TEAM INC | $1,395,000 | – | 60,400 | +100.0% | 0.06% | – |
| PTIE | PAIN THERAPEUTICS INC | $1,333,000 | -70.9% | 647,053 | 0.0% | 0.05% | -73.9% | |
| TWMC | Sell | TRANS WORLD ENTMT CORP | $629,000 | -66.7% | 722,647 | -52.1% | 0.02% | -70.6% |
| FNTEW | FINTECH ACQUISITION CORP II*w exp 01/19/202 | $400,000 | +21.2% | 249,999 | 0.0% | 0.02% | +6.7% | |
| RBCAA | REPUBLIC BANCORP KYcl a | $334,000 | +18.4% | 7,371 | 0.0% | 0.01% | +7.7% | |
| CRMT | Exit | AMERICAS CAR MART INC | $0 | – | -16,348 | -100.0% | -0.04% | – |
| AGS | Exit | PLAYAGS INC | $0 | – | -399,158 | -100.0% | -0.42% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -100,000 | -100.0% | -0.48% | – |
| CGNT | Exit | COGENTIX MED INC | $0 | – | -3,639,853 | -100.0% | -0.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.